Driving Timely Biomarker Testing to Optimize Treatment Decisions for Colorectal Cancer Patients Across Canada
Pfizer
Canadian organizations and institutions to pursue innovative approaches for Research or QI projects that aim to optimize biomarker testing for patients in CRC at the applicants’ centre. Applicants are invited to implement innovative ideas with the goal of creating a path for sustainable biomarker testing for mCRC patients in Canada.
Applicants must submit a Research or QI project budget for a maximum of $100,000 CAD.
Deadlines
| UM Internal Deadline (to ADR) | Sponsor Deadline | |
|---|---|---|
Application | 25-Mar-2026 | 15-Apr-2026 11:59 pm EST |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.